Literature DB >> 23427250

A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells.

Zhiyong Guo1, Mithun Khattar, Paul M Schroder, Yoshihiro Miyahara, Guohua Wang, Xiaoshung He, Wenhao Chen, Stanislaw M Stepkowski.   

Abstract

The molecular mechanism of the extrathymic generation of adaptive, or inducible, CD4(+)Foxp3(+) regulatory T cells (iTregs) remains incompletely defined. We show that exposure of splenic CD4(+)CD25(+)Foxp3(-) cells to IL-2, but not other common γ-chain cytokines, resulted in Stat5 phosphorylation and induced Foxp3 expression in ∼10% of the cells. Thus, IL-2/Stat5 signaling may be critical for Foxp3 induction in peripheral CD4(+)CD25(+)Foxp3(-) iTreg precursors. In this study, to further define the role of IL-2 in the formation of iTreg precursors as well as their subsequent Foxp3 expression, we designed a two-step iTreg differentiation model. During the initial "conditioning" step, CD4(+)CD25(-)Foxp3(-) naive T cells were activated by TCR stimulation. Inhibition of IL-2 signaling via Jak3-Stat5 was required during this step to generate CD4(+)CD25(+)Foxp3(-) cells containing iTreg precursors. During the subsequent Foxp3-induction step driven by cytokines, IL-2 was the most potent cytokine to induce Foxp3 expression in these iTreg precursors. This two-step method generated a large number of iTregs with relatively stable expression of Foxp3, which were able to prevent CD4(+)CD45RB(high) cell-mediated colitis in Rag1(-/-) mice. In consideration of this information, whereas initial inhibition of IL-2 signaling upon T cell priming generates iTreg precursors, subsequent activation of IL-2 signaling in these precursors induces the expression of Foxp3. These findings advance the understanding of iTreg differentiation and may facilitate the therapeutic use of iTregs in immune disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427250      PMCID: PMC3608742          DOI: 10.4049/jimmunol.1200751

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  "Default" generation of neonatal regulatory T cells.

Authors:  Guohua Wang; Yoshihiro Miyahara; Zhiyong Guo; Mithun Khattar; Stanislaw M Stepkowski; Wenhao Chen
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

2.  IL-2-deprivation and TGF-beta are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25- cell activation.

Authors:  Guohua Wang; Mithun Khattar; Zhiyong Guo; Yoshihiro Miyahara; Sean P Linkes; Zongquan Sun; Xiaoshun He; Stanislaw M Stepkowski; Wenhao Chen
Journal:  Immunol Lett       Date:  2010-06-08       Impact factor: 3.685

Review 3.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.

Authors:  Kieng B Vang; Jianying Yang; Shawn A Mahmud; Matthew A Burchill; Amanda L Vegoe; Michael A Farrar
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 5.  Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

Review 6.  Control of regulatory T cell lineage commitment and maintenance.

Authors:  Steven Z Josefowicz; Alexander Rudensky
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

7.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

8.  Identification of an immediate Foxp3(-) precursor to Foxp3(+) regulatory T cells in peripheral lymphoid organs of nonmanipulated mice.

Authors:  Sonja Schallenberg; Pei-Yun Tsai; Julia Riewaldt; Karsten Kretschmer
Journal:  J Exp Med       Date:  2010-06-28       Impact factor: 14.307

9.  IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells.

Authors:  Yenkel Grinberg-Bleyer; Audrey Baeyens; Sylvaine You; Rima Elhage; Gwladys Fourcade; Sylvie Gregoire; Nicolas Cagnard; Wassila Carpentier; Qizhi Tang; Jeffrey Bluestone; Lucienne Chatenoud; David Klatzmann; Benoît L Salomon; Eliane Piaggio
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

10.  In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.

Authors:  Kylie E Webster; Stacey Walters; Rachel E Kohler; Tomas Mrkvan; Onur Boyman; Charles D Surh; Shane T Grey; Jonathan Sprent
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

View more
  10 in total

1.  Deoxyhypusine synthase promotes differentiation and proliferation of T helper type 1 (Th1) cells in autoimmune diabetes.

Authors:  Stephanie C Colvin; Bernhard Maier; David L Morris; Sarah A Tersey; Raghavendra G Mirmira
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

2.  Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells.

Authors:  Jin-Kwan Lee; Seo-Young Koo; Hye-Mi Nam; Jee-Boong Lee; Jiwon Ko; Kyung-Mo Kim; Eun-Ji Park; Tae Jin Kim; Ho Lee; Heounjeong Go; Chang-Woo Lee
Journal:  Cell Mol Immunol       Date:  2021-04-13       Impact factor: 22.096

3.  Interleukin-21 is a critical regulator of CD4 and CD8 T cell survival during priming under Interleukin-2 deprivation conditions.

Authors:  Mithun Khattar; Yoshihiro Miyahara; Paul M Schroder; Aini Xie; Wenhao Chen; Stanislaw M Stepkowski
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

4.  Relationship between immune parameters and organ involvement in children with Henoch-Schonlein purpura.

Authors:  Yan-xiang Pan; Qing Ye; Wen-xia Shao; Shi-qiang Shang; Jian-hua Mao; Ting Zhang; Hong-qiang Shen; Ning Zhao
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 5.  Transcriptional and epigenetic regulation of T-helper lineage specification.

Authors:  Subhash K Tripathi; Riitta Lahesmaa
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

6.  Chicken-Specific Kinome Array Reveals that Salmonella enterica Serovar Enteritidis Modulates Host Immune Signaling Pathways in the Cecum to Establish a Persistence Infection.

Authors:  Michael H Kogut; Christina L Swaggerty; James Allen Byrd; Ramesh Selvaraj; Ryan J Arsenault
Journal:  Int J Mol Sci       Date:  2016-07-27       Impact factor: 5.923

7.  A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect.

Authors:  Andrew N de la Torre; Sohail Contractor; Ismael Castaneda; Charles S Cathcart; Dolly Razdan; David Klyde; Piotr Kisza; Sharon F Gonzales; Andres M Salazar
Journal:  J Hepatocell Carcinoma       Date:  2017-08-07

Review 8.  Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?

Authors:  Shiyi Zuo; Jiaxuan Song; Jingxuan Zhang; Zhonggui He; Bingjun Sun; Jin Sun
Journal:  Theranostics       Date:  2021-06-01       Impact factor: 11.556

9.  Cytokine regulation of immune tolerance.

Authors:  Jie Wu; Aini Xie; Wenhao Chen
Journal:  Burns Trauma       Date:  2014-01-26

10.  Prostaglandin E2 directly inhibits the conversion of inducible regulatory T cells through EP2 and EP4 receptors via antagonizing TGF-β signalling.

Authors:  Marie Goepp; Siobhan Crittenden; You Zhou; Adriano G Rossi; Shuh Narumiya; Chengcan Yao
Journal:  Immunology       Date:  2021-10-01       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.